previous compound ID: 126 next compound
InChIKey: AGOYDEPGAOXOCK-KCBOHYOISA-N
SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "E Matthes" "JW Hanrahan" "R Robert" "J Goepp" "GW Carlile" "SD Macknight" "DY Thomas" "J Liao" "D Rotin"

chemical graph of compound 126





CID is 84029
synonyms found at PubChem are:
clarithromycin, 81103-11-9, Biaxin, Clarithromycine, Klaricid, 6-O-Methylerythromycin, Clathromycin, 6-O-Methylerythromycin a, Abbott-56268, Macladin, Clarith, Kofron, Veclam, Clarithromycinum, Naxy, A-56268, Claritromicina, TE-031, Abbotic, Astromen, Bicrolid, Clacine, Clambiotic, Claribid, Claricide, Claridar, Claripen, Fromilid, Heliclar, Klaciped, Mabicrol, Clacee, Clacid, Clarem, Crixan, Cyllid, Klabax, Klarid, Klarin, Maclar, Helas, Mavid, Adel, Biaxin filmtab, Erythromycin, 6-O-methyl-, Klax, Biaxin HP, Biaxin xl filmtab, Klaricid Pediatric, Klacid, Vikrol, Clari, Infex, Biaxin XL, DRG-0099, UNII-H1250JIK0A, Clarithromycine [INN-French], Clarithromycinum [INN-Latin], Claritromicina [INN-Spanish], Zeclar, CHEBI:3732, H1250JIK0A, C38H69NO13, Klaricid H.P., CPD000466382, clarithromycina, Cyllind, Clarithromycin extended release, Klaricid XL, (14R)-14-Hydroxyclarithromycin, Klaricid H.P, TE031, Biaxin (TN), Clarithromycin [USAN:INN:BAN:JAN], (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, CTY, SMR000466382, O(6)-methylerythromycin, SR-05000001992, Lactoferrin B & Clarithromycin, Lactoferrin H & Clarithromycin, Clarithromycin (Biaxin, Klacid), Clarithromycin & Interleukin-12, CLM & IL-12, ANX-015, clamicin, SDP-015, Clarithromycin suspension or tablets, CCRIS 8833, HSDB 8055, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, Clarithromycin,(S), Spectrum_000089, Clarithromycin [USAN:USP:INN:BAN:JAN], SpecPlus_000559, 6-O-methyl erythromycin, 6-O-Methyl-erythromycin, CLA;, Spectrum2_001668, Spectrum3_001667, Spectrum4_000629, Spectrum5_001729, 6-0-methylerythromycin A, AC1L36NJ, CHEMBL1741, SCHEMBL38125, BSPBio_003453, KBioGR_001218, KBioSS_000509, MLS000759516, MLS001201751, MLS001424066, BIDD:GT0200, DivK1c_006655, SPECTRUM1504231, SPBio_001855, CHEMBL3764720, DTXSID3022829, KBio1_001599, KBio2_000509, KBio2_003077, KBio2_005645, KBio3_002673, AGOYDEPGAOXOCK-KCBOHYOISA-N, Clarithromycin (JP17/USP/INN), MolPort-002-507-425, Clarithromycin, >=95% (HPLC), Clarithromycin, >=98% (HPLC), HMS1922H09, HMS2051G18, HMS2090O11, HMS2094M05, HMS2231A08, HMS3715J17, Pharmakon1600-01504231, EBD13493, BDBM50404044, CCG-39086, LMPK04000014, MFCD00865140, NSC758704, s2555, ZINC85534098, C30H54O11.C9H19NO2, AKOS015894242, CS-2576, DB01211, LS-1812, MCULE-7168853332, NC00140, NSC-758704, NCGC00178054-01, CC-25899, H781, HY-17508, SAM001246748, SBI-0206716.P001, FT-0602940, C06912, D00276, J10130, AB00053394-10, AB00053394-12, AB00053394-13, AB00053394_14, AB00053394_15, 103C119, C-23486, Q-200870, SR-05000001992-1, SR-05000001992-2, BRD-K49668410-001-07-1, BRD-K49668410-001-18-8, Clarithromycin, European Pharmacopoeia (EP) Reference Standard, Clarithromycin, United States Pharmacopeia (USP) Reference Standard, Clarithromycin Identity, United States Pharmacopeia (USP) Reference Standard, Clarithromycin, Ready Made Solution, 50 mg/mL in DMSO, 0.2 mum filtered, Clarithromycin for peak identification, European Pharmacopoeia (EP) Reference Standard, Clarithromycin, Pharmaceutical Secondary Standard; Certified Reference Material, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, 6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione